Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Untreated Operable Early Breast Cancer × palbociclib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 51 Sarcoma 6 Squamous Cell Carcinoma of Head and Neck 5 Neoplasms 5 Neoplasm Metastasis 5 Sarcoma, Ewing 4 Ovarian Neoplasms 4 Lymphoma, Non-Hodgkin 4 Rhabdomyosarcoma 3 Rhabdoid Tumor 3 Osteosarcoma 3 Neuroblastoma 3 Multiple Myeloma 3 Medulloblastoma 3 Carcinoma, Non-Small-Cell Lung 3 Wilms Tumor 2 Prostatic Neoplasms 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Lymphoma 2 Liposarcoma 2 Histiocytosis, Langerhans-Cell 2 Hepatoblastoma 2 Head and Neck Neoplasms 2 Glioma 2 Estrogen Receptor-positive Breast Cancer 2 Ependymoma 2 Endometrial Neoplasms 2 Colorectal Neoplasms 2 Chordoma 2 Carcinoma, Squamous Cell 2

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02008734 2016-06-09

POP

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Completed

Untreated Operable Early Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡